Approvals/TGA/XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial

Approved

STANDARD

XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial

Grifols Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d4439b8d93ba6692
Product Name: XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial
Artg Id: 380406
Artg Name: XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial
Sponsor: Grifols Australia Pty Ltd
Company Detail Path: /organization/grifols-australia-pty-ltd
Artg Date: 2022-06-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01658-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01660-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d4439b8d93ba6692

Type

Standard